Construction of oral squamous cell carcinoma organoids in vitro 3D‐culture for drug screening
Oral Diseases · 2025-01 · 31 (1) · 99-109
DOI: 10.1111/odi.15044 ↗At a glance
Journal article in Oral Diseases, published online on 2024-06-18. Written by Xin-Yuan Zhang and 6 co-authors. Institution: Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing, China. Major MEDLINE topics: Organoids, Mouth Neoplasms, Carcinoma, Squamous Cell, Antineoplastic Agents. Cited 15 times so far (Crossref); 23 references. Funded by: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (original language)
Objective
Patient‐derived organoids are potent pre‐chemotherapy models. Due to limited research on diverse types of oral squamous cell carcinoma (OSCC) and construction efficiency, our goal was to optimize OSCC organoid models from various sites and assess drug responsiveness.
Methods
We screened and optimized culture media, employing three‐dimensional techniques to construct human‐derived oral squamous cell carcinoma (OSCC) organoid models in vitro. Morphological validation, immunofluorescence analysis, tissue origin verification, and Short Tandem Repeat (STR) sequencing confirmed the consistency between organoids and source tissues. These organoid models were then subjected to varying concentrations of anticancer drugs, with subsequent assessment of cell viability to calculate IC50 values.
Results
Twenty‐nine surgical specimens yielded an 86.2% success rate in culturing 25 organoids in vitro. Morphological consistency confirmed nuclear atypia and positive expression of K5, P40, and E‐cadherin, indicating squamous epithelial origin. Cultured complex organoids included α‐SMA+ tumour‐associated fibroblasts and tumour stem cells expressing CD44 and Ki67. STR sequencing affirmed genomic homogeneity between cultured organoids and source tissues. Drug sensitivity testing revealed diverse responses among organoids, highlighting their value for assessing drug sensitivity.
Conclusions
An efficient OSCC organoid culture system for personalized in vitro drug sensitivity screening was established, laying the foundation for precise treatment development.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing, China.
- National Center for Stomatology, Beijing, China.
- National Clinical Research Center for Oral Diseases, Beijing, China.
- National Engineering Research Center of Oral Biomaterials and Digital Medical Devices, Beijing, China.
- Department of Oral Emergency, Peking University School and Hospital of Stomatology, Beijing, China.
ORCID profiles: Xiao-Feng Shan, Zhi-Gang Cai
Funding
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Cite
APA
Zhang, X. Y., Sui, Y., Shan, X. F., Wang, L. M., Zhang, L., Xie, S., & Cai, Z. G. (2025). Construction of oral squamous cell carcinoma organoids in vitro 3D‐culture for drug screening. Oral Diseases, 31(1), 99-109. https://doi.org/10.1111/odi.15044
Vancouver
Zhang XY, Sui Y, Shan XF, Wang LM, Zhang L, Xie S, et al. Construction of oral squamous cell carcinoma organoids in vitro 3D‐culture for drug screening. Oral Diseases. 2025;31(1):99-109. doi:10.1111/odi.15044
BibTeX
@article{Zhang2025,
author = {Zhang, Xin-Yuan and Sui, Yi and Shan, Xiao-Feng and Wang, Lu-Ming and Zhang, Lei and Xie, Shang and Cai, Zhi-Gang},
title = {Construction of oral squamous cell carcinoma organoids in vitro 3D‐culture for drug screening},
journal = {Oral Diseases},
year = {2025},
volume = {31},
number = {1},
pages = {99--109},
doi = {10.1111/odi.15044}
}
EUVIMED